The primary proposed benefits of Dihexa focus on neuroregeneration, memory consolidation, and cognitive enhancement. Dihexa is an investigational, synthetic peptide derived from angiotensin IV that easily crosses the blood-brain barrier. It acts as a hepatocyte growth factor (HGF) mimetic, binding to c-Met receptors to structurally alter and rebuild neural pathways.
Synaptogenesis and Brain Repair: It stimulates the formation of new functional synapses and dendritic spines between neurons. This structural rebuilding helps patch damaged neural networks.
High Potency Neuroplasticity: In early laboratory assays, it demonstrated neurotrophic activity significantly more potent than Brain-Derived Neurotrophic Factor (BDNF). This allows the brain to rapidly adapt, rewire, and heal from injuries.
Memory and Learning Enhancement: In animal models, it has been shown to improve spatial learning, accelerate memory consolidation, and improve recall. It is noted for its ability to clear scopolamine-induced memory deficits in rodents.
Neurodegenerative Support: Due to its ability to slow down or reverse experimental cognitive decline, it is actively researched for its therapeutic potential against Alzheimer’s disease, dementia, and traumatic brain injuries.
Anti-Inflammatory Properties: Preclinical data indicates it downregulates pro-inflammatory cytokines (such as IL-1β and TNF-α) while increasing anti-inflammatory signals in brain tissue, potentially easing neuroinflammation.